LCZ 696, administered during doxorubicin, trastuzumab or pertuzumab treatment, prevents cardiotoxicity in our in vitro modelNicola Maurea, Claudia De Lorenzo, Rolando Paciello et al.|Annals of Oncology|2017Cited by 4
Ranolazine and TDM1 treatment: Cardioprotective effects in vitro and in vivo.Nicola Maurea, Gennaro Riccio, Domenica Rea et al.|Journal of Clinical Oncology|2017Cited by 0